Development of a sandwich ELISA for evaluating soluble OX40L (CD252) in human sera of different ages or with Graves' disease
about
Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritisSimvastatin reduces OX40 and OX40 ligand expression in human peripheral blood mononuclear cells and in patients with atherosclerotic cerebral infarction.Enforced covalent trimerisation of soluble feline CD134 (OX40)-ligand generates a functional antagonist of feline immunodeficiency virus.OX40, OX40L and Autoimmunity: a Comprehensive Review.Soluble B7-H2 as a novel marker in early evaluation of the severity of acute pancreatitis.
P2860
Development of a sandwich ELISA for evaluating soluble OX40L (CD252) in human sera of different ages or with Graves' disease
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Development of a sandwich ELIS ...... t ages or with Graves' disease
@ast
Development of a sandwich ELIS ...... t ages or with Graves' disease
@en
Development of a sandwich ELIS ...... t ages or with Graves' disease
@en-gb
Development of a sandwich ELIS ...... t ages or with Graves' disease
@nl
type
label
Development of a sandwich ELIS ...... t ages or with Graves' disease
@ast
Development of a sandwich ELIS ...... t ages or with Graves' disease
@en
Development of a sandwich ELIS ...... t ages or with Graves' disease
@en-gb
Development of a sandwich ELIS ...... t ages or with Graves' disease
@nl
prefLabel
Development of a sandwich ELIS ...... t ages or with Graves' disease
@ast
Development of a sandwich ELIS ...... t ages or with Graves' disease
@en
Development of a sandwich ELIS ...... t ages or with Graves' disease
@en-gb
Development of a sandwich ELIS ...... t ages or with Graves' disease
@nl
P2093
P1433
P1476
Development of a sandwich ELIS ...... t ages or with Graves' disease
@en
P2093
Xuefeng Wang
Xueguang Zhang
Yongjing Chen
P356
10.1016/J.CYTO.2006.10.006
P407
P577
2006-10-01T00:00:00Z